Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability and food effect study of nizubaglustat formulations in healthy volunteers
NL-OMON60174Phase 1Completed
- Sponsor
- Azafaros
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nizubaglustat in Glycosphingolipid lysosomal storage disease (GSL-LSD) (2 arms), sponsored by Azafaros. Started Mar 2024; status: completed.
02
Drugs
nizubaglustat
03
Conditions
Glycosphingolipid lysosomal storage disease (GSL-LSD)
Beyond the preview
Go deeper on NL-OMON60174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60174.